BluePath Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

BluePath Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.33M	Sell	21,289 -916	-4%	-$57.9K	0.69%	55
2026 Q2	$1.28M	Buy	22,205 +656	+3%	+$37.7K	0.7%	46
2026 Q1	$1.31M	Buy	21,549 +256	+1%	+$14.9K	0.9%	28
2025 Q4	$1.15M	Buy	21,293 +3,508	+20%	+$169K	0.78%	44
2025 Q3	$802K	Buy	17,785 +4,390	+33%	+$205K	0.59%	68
2025 Q2	$620K	Buy	+13,395	New	+$658K	0.55%	68
2023 Q4	–	Sell	-891	Closed	-$51.7K	–	132
2023 Q3	$51.7K	Buy	+891	New	+$54.6K	0.05%	186

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

BluePath Capital Management's BMY Position: Q3 2026 in Review

BluePath Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 4.1% in Q3 2026, selling an estimated $57.9K and leaving 21,289 shares worth $1.33M. The position accounts for 0.69% of the portfolio, ranked #55.

BluePath Capital Management first reported a position in BMY in Q3 2023 and has held it in 7 quarters since. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

BluePath Capital Management held 21,289 shares of Bristol-Myers Squibb worth $1.33M as of Q3 2026.
BluePath Capital Management sold 916 Bristol-Myers Squibb shares in Q3 2026, an estimated $57.9K.
Bristol-Myers Squibb made up 0.69% of BluePath Capital Management's portfolio in Q3 2026, its #55 holding.
BluePath Capital Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 7 quarters since.
907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.